Abstract:Objective To investigate the role of circulating Th17 cells and IL-17 in myasthenia gravis(MG).Methods Forty MG patients and 10 healthy controls(HC) were recruited.The proportion of Th17 cells in peripheral blood mononuclear cells(PBMCs) was detected via flow cytometry.The transcription factor RORγt mRNA expression in PBMCs was detected with Reverse Transcription-Polymerase Chain Reaction (RT-PCR).The concentration of cytokine IL-17 in sera was measured by ELISA.The anti-human AChR antibody in the serum was assayed using the radioimmunoprecipitation method.CD19+ B cells and CD4+ T cells were isolated from PBMCs of MG patients and healthy controls at the presence of SEB.The anti-AChR antibody secretion in T/B cells co-culture supernatant was detected by radioimmunoprecipitation.The effects of inhibiting IL-17 or IL-21 were examined by adding anti-IL-17 or IL-21 neutralizing antibody in the co-culture system.A quantitative MG scoring system (QMG score) was used to objectively evaluate the disease severity.Then, we analyzed the correlation between Th17 cells proportion, serum IL-17 level, RORγt mRNA and QMG scores.Results The percentage of Th17 cells increased significantly in PBMCs of MG patients compared with HC(P<0.0001), and Th17 cells counts was positively correlated with disease severity(r=0.4394, P=0.0046).Th17 cell-associated transcription factors RORγt mRNA and cytokines IL-17 expression elevated in MG patients(P<0.001).The titers of anti-AChR antibody(AChR-Ab)increased significantly in MG patients compared with HC(P<0.001), and the titer of AChR-Ab was positively correlated with disease severity.High level of anti-AChR antibody was detected in the co-culture of patients T and B cells.Blocking IL-17 or IL-21 alone by neutralizing antibodies led to a moderate decrease of anti-AChR antibody titer, while simultaneous blockage of IL-17 and IL-21 resulted in dramatically decrease of anti-AChR antibody titer.Conclusions In creased Th17 cell was involved in the pathological process of MG, and exacerbated its severity probably via enhanced AChR-Ab production.

Changes of Tfh cells in peripheral blood and its significance in the patients with myasthenia gravis

High Frequencies of Circulating Tfh-Th17 Cells in Myasthenia Gravis Patients

Changes of circulating T helper 22 cells and its related molecules in myasthenia gravis

Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis

Non-neuronal cholinergic activity is potentiated in myasthenia gravis

The Change and Relevant Significance of Th1/Th2/Th17 Cytokines in Myasthenia Gravis

Augmentation Of Circulating Follicular Helper T Cells And Their Impact On Autoreactive B Cells In Myasthenia Gravis

The correlation between the expression of AIRE, Tfh and Tfr cells and clinical severity in myasthenia gravis patients

Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis

The circulating Th17 cells enhance AChR antibody production in myasthenia gravis patients

Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients.

Expression of Tfh Cells and Molecules in Peripheral Blood from OMG and GMG Patients

Imbalance of Circulating CD4+CXCR5+FOXP3+ Tfr-like Cells and CD4+CXCR5+FOXP3− Tfh-like Cells in Myasthenia Gravis

Dynamic study of circulating CD_4~+CD_(25)~(high) T cells in myasthenia gravis

Changes of Treg-Associated Molecules on CD4 + CD25 + Treg Cells in Myasthenia Gravis and Effects of Immunosuppressants

Changes of regulatory T cells in peripheral blood of patients with myasthenia gravis and the effect of immu-nosuppressive treatment

Study of circulating Th17 cells and associated cytokines in myasthenia gravis

Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence

Central Role of T Follicular Helper Cells in Myasthenia Gravis

Changes of B cell subsets characterized with CD27 and CD38 phenotypes in peripheral blood of myasthenia gravis patients

Increased Frequency of Thymic T Follicular Helper Cells in Myasthenia Gravis Patients with Thymoma